Clinical Trial Update: Efficacy of Valproate in Peripheral Neuropathic Pain [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating valproate for neuralgia and peripheral neuropathic pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia
• Neuropathic Pain

Drugs mentioned

• Valproate (valproate)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Neuralgia, Neuropathic Peripheral Pain | Phase 2, Phase 3 | Status: TERMINATED